Naoko Wada Selected Research

Naoko Wada Research Topics

Disease

13	Melanoma (Melanoma, Malignant) 11/2020 - 10/2013
12	Neoplasms (Cancer) 03/2019 - 11/2003
5	Pemphigus (Pemphigus Vulgaris) 01/2022 - 02/2011
5	Multiple Myeloma 05/2018 - 09/2012
4	Dermatitis 12/2021 - 09/2011
3	Disease Progression 10/2018 - 11/2015
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2019 - 05/2017
2	Hypoxia (Hypoxemia) 05/2018 - 12/2013
2	Hypersensitivity (Allergy) 10/2016 - 11/2015
2	Intracranial Aneurysm (Cerebral Aneurysm) 10/2016 - 11/2015
1	Ketosis 01/2022
1	Blister (Bulla) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Infections 10/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2018
1	Hemangiosarcoma (Angiosarcoma) 01/2018
1	Bullous Pemphigoid (Pemphigoid) 10/2017
1	Edema (Dropsy) 08/2017
1	Synovitis 08/2017
1	Neoplasm Metastasis (Metastasis) 01/2015
1	Nevus (Nevi) 10/2013
1	Diabetes Complications 07/2013
1	Breast Neoplasms (Breast Cancer) 12/2012
1	Skin Diseases (Skin Disease) 09/2011
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2010
1	Hyperpigmentation 02/2009
1	Cystic Fibrosis (Mucoviscidosis) 07/2005
1	Intellectual Disability (Idiocy) 07/2005
1	Chronic Obstructive Pulmonary Disease (COPD) 07/2005
1	Stroke (Strokes) 07/2005
1	Pulmonary Atelectasis 07/2005
1	Quadriplegia (Spastic Quadriplegia) 07/2005
1	Respiratory Insufficiency (Respiratory Failure) 07/2005
1	Neuromuscular Diseases (Neuromuscular Disease) 07/2005
1	Aspiration Pneumonia 07/2005
1	Infantile Spasms (West Syndrome) 01/2004
1	Atrophy 01/2004
1	Lactic Acidosis 01/2004

Drug/Important Bio-Agent (IBA)

8	NivolumabIBA 11/2020 - 05/2017
4	Desmoglein 3IBA 01/2022 - 02/2011
4	IpilimumabIBA 11/2020 - 12/2018
3	Immune Checkpoint InhibitorsIBA 01/2019 - 05/2017
3	Programmed Cell Death 1 ReceptorIBA 01/2019 - 01/2018
3	AntibodiesIBA 01/2019 - 06/2011
2	Immunoglobulin G (IgG)IBA 01/2022 - 06/2011
2	DesmogleinsIBA 01/2022 - 09/2011
2	AntigensIBA 12/2021 - 06/2011
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2019 - 05/2017
2	Monoclonal AntibodiesIBA 01/2019 - 06/2018
2	SteroidsIBA 01/2019 - 02/2009
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2018
2	pembrolizumabIBA 01/2018 - 10/2017
2	PlatinumIBA 10/2016 - 11/2015
2	MetalsIBA 10/2016 - 11/2015
2	Lenalidomide (CC 5013)FDA Link 01/2016 - 09/2012
2	AutoantigensIBA 09/2011 - 02/2011
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Interleukin-4 (Interleukin 4)IBA 01/2022
1	LipidsIBA 01/2022
1	CarbohydratesIBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	GlycogenIBA 01/2022
1	SolutionsIBA 03/2019
1	GlucocorticoidsIBA 01/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019
1	Panton-Valentine leukocidinIBA 10/2018
1	dabrafenibIBA 07/2018
1	trametinibIBA 07/2018
1	anti-thyroglobulinIBA 06/2018
1	Peroxidase (Myeloperoxidase)IBA 06/2018
1	Oxygen (Dioxygen)IBA 05/2018
1	bufalinIBA 05/2018
1	eribulin FDA Link 01/2018
1	Collagen Type XVIIIBA 10/2017
1	pomalidomideIBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	Thalidomide (Thalomid)FDA Link 01/2016
1	Immunomodulating AgentsIBA 01/2016
1	Proteasome InhibitorsIBA 03/2015
1	shikoninIBA 03/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2015
1	Bortezomib (Velcade)FDA Link 12/2013
1	Cathepsin DIBA 10/2013
1	AutoantibodiesIBA 06/2011
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2010
1	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2010
1	AclarubicinIBA 05/2010
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2009
1	Dapsone FDA Link 02/2009
1	EnzymesIBA 01/2004
1	pyruvate dehydrogenase E1alpha subunitIBA 01/2004
1	Arsenic Trioxide (Trisenox)FDA Link 11/2003

Therapy/Procedure

6	Therapeutics 11/2020 - 12/2012
2	Drug Therapy (Chemotherapy) 11/2020 - 04/2011
2	Immunotherapy 01/2019 - 01/2018
1	Glycemic Control 07/2013
1	Tracheostomy 07/2005
1	Artificial Respiration (Mechanical Ventilation) 07/2005
1	Mechanical Ventilators (Ventilator) 07/2005
1	Intravenous Injections 11/2003